BTF acquired by bioMerieux
Australian company BTF Decisive Microbiology has been acquired by bioMerieux. French clinical diagnostics company bioMérieux is present in more than 150 countries through 35 subsidiaries and has a large network of distributors.
The new acquisition will make BTF's products more accessible to a wider distribution network.
Initially, BTF will operate as a standalone subsidiary, so all existing customers will not see any changes in the short term. BTF's contact details remain unchanged.
NSW Govt to launch science and innovation fund
The fund will be used to coordinate strategic investments, deliver on government priorities and...
DKSH brings Bioyond Robotics' lab automation products Down Under
DKSH will provide distribution of the Bioyond Robotics portfolio of AI-driven autonomous...
Immunologist wins GSK Award for respiratory virus research
Award winner Professor Katherine Kedzierska seeks to answer an important question: why do some...
